Hellenic Center for Disease Control & Prevention · 1×
×1218k/1kMM
×114k/373AMB
×6.95k/676ENDOC
×113k/245CCICM
×8.03k/371CB
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at Alfa Institute of Biomedical Sciences
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Alfa Institute of Biomedical Sciences. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Alfa Institute of Biomedical Sciences with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfa Institute of Biomedical Sciences more than expected).
Fields of papers published by authors at Alfa Institute of Biomedical Sciences
This network shows the impact of papers affiliated with Alfa Institute of Biomedical Sciences at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Alfa Institute of Biomedical Sciences at the time of their publication.
About Alfa Institute of Biomedical Sciences
In recent decades, authors affiliated with Alfa Institute of Biomedical Sciences have published 680 papers, which have received a total of 56.7k indexed citations . Scholars at this organization have produced 152 papers in Molecular Medicine, 46 papers in Applied Microbiology and Biotechnology, 47 papers in Critical Care and Intensive Care Medicine, 199 papers in Epidemiology and 106 papers in Infectious Diseases on the topics of Antibiotic Resistance in Bacteria (152 papers), Antibiotics Pharmacokinetics and Efficacy (87 papers), Pneumonia and Respiratory Infections (70 papers), Urinary Tract Infections Management (48 papers), Antibiotic Use and Resistance (46 papers), Nosocomial Infections in ICU (45 papers), Antimicrobial Resistance in Staphylococcus (44 papers) and Bacterial Identification and Susceptibility Testing (32 papers). Their work is cited by papers focused on Molecular Medicine (17.7k citations), Applied Microbiology and Biotechnology (4.1k citations), Endocrinology (4.7k citations), Critical Care and Intensive Care Medicine (2.6k citations) and Clinical Biochemistry (3.0k citations). Authors at Alfa Institute of Biomedical Sciences collaborate with scholars in Greece, United States and United Kingdom and have published in prestigious journals including International Journal of Antimicrobial Agents, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Expert Review of Anti-infective Therapy and PLoS ONE. Some of Alfa Institute of Biomedical Sciences's most productive authors include Matthew E. Falagas, Drosos E. Karageorgopoulos, Konstantinos Z. Vardakas, Petros I. Rafailidis, Georgios Pappas, Eleni I. Pitsouni, M. E. Falagas, Argyris S. Michalopoulos, George A. Malietzis and S. K. Kasiakou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact